Michael Walter

Michael Walter
Managing Editor


Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

FDA approves acoramidis, BridgeBio’s new ATTR-CM drug
Medtronic receives key FDA clearance, launches new diabetes system
TAVR technology keeps evolving, improving outcomes without compromising valve performance
Q&A: How supra-annular, self-expanding TAVR valves open up options for future interventions
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation
Cardiologists reflect on developing primary PCI in face of criticism and pushback
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
FDA clears AI screening tool for cardiac amyloidosis
IVUS-guided PCI reduces risks in patients with diabetes